The study of physicochemical and pharmacotechnological properties of active substances in the composition of sublingual tablets

Authors

  • O. Yakovenko National University of Pharmacy, Ukraine
  • O. Ruban National University of Pharmacy, Ukraine

DOI:

https://doi.org/10.24959/ubphj.19.244

Keywords:

stress, sublingual tablets, pharmacotechnological studies

Abstract

Topicality. Every year there is new evidence of stress effect on everyday life and, as a consequence, the development of systemic diseases (atherosclerosis, coronary heart disease, pathological insomnia), therefore, the creation of an original combination drug for its prevention is a relevant task today.
Aim. To conduct pharmacotechnological and physico-chemical studies of active pharmaceutical ingredients (API) to select the optimal technology for the production of sublingual tablets.
Materials and methods. Glycine and magnesium citrate were chosen as the API, pharmacotechnological and physicchemical studies of which were carried out in accordance with the requirements of the State Pharmacopoeia of Ukraine.
Results and discussion. Crystallographic studies showed a significant difference in the form factor between glycine and magnesium citrate (0.49 and 0.18, respectively). Both APIs are non-hygroscopic, but magnesium citrate has better flowability (8.48 s/100 g) as opposed to glycine (40.52 s/100 g). The particle size distribution of API was studied (glycine is almost evenly distributed between No. 0, No. 0.1 and No. 0.5 sieves, magnesium citrate is sieved through No. 0 sieve).
Conclusions. Based on the results of the studies, the difference in the main technological characteristics of glycine and magnesium citrate is determined. In this regard, there is a need to choose excipients for the production of sublingual tablets by method of direct compression.

Author Biographies

O. Yakovenko, National University of Pharmacy

PhD student of  the Department of Industrial Technology of Drugs

O. Ruban, National University of Pharmacy

Doctor of Pharmacy, Professor, head of the Department of Industrial Technology of Drugs

References

Selye, H. (1982). Stress without distress (trans. A. N. Luka, I. S. Khorola). Moscow: Progress, 128.

Dhabhar, F. S. (2014). Effects of stress on immune function: the good, the bad, and the beautiful. Immunologic Research, 58 (2–3), 193–210. https://doi.org/10.1007/s12026-014-8517-0

Bunker, S. J., Colquhoun, D. M., Esler, M. D., Hickie, I. B., Hunt, D., Jelinek, V. M., Oldenburg, B. F., Peach, H. G., Ruth, D., Tennant, C. C., Tonkin, A. M. (2003). Stress and coronary heart disease: psychosocial risk factors. The Medical journal of Australia, March, 178, 272–276.

Krantz, D. S., Whittaker, K. S., & Sheps, D. S. (2011). Psychosocial risk factors for coronary heart disease: Pathophysiologic mechanisms. In R. Allan & J. Fisher, Heart and mind: The practice of cardiac psychology (pp. 91–113). Washington, DC, US : American Psychological Association. http://dx.doi.org/10.1037/13086-004

Piefke, M., & Glienke, K. (2017). The effects of stress on prospective memory: A systematic review. Psychology & Neuroscience, 10 (3), 345–362. http://dx.doi.org/10.1037/pne0000102

American Psychological Association. (2018). Stress in America : Generation Z. Stress in America™ Survey. Available at: https://www.apa.org/news/press/releases/stress/2018/stress-gen-z.pdf

Yakovenko, O. V., Ruban, O. A., & Hrynenko, V. V. (2018). The marketing research of drugs for prevention and treatment of stress conditions at the pharmaceutical market of Ukraine. Vìsnik Farmacìï, 4 (96), 52–56. https://doi.org/10.24959/nphj.18.2229

Tarasov, E. A., Blinov, D. V., Zimovina, U. V., Sandakova, E. A. (2015). Magnesium deficiency and stress: Issues of their relationship, diagnostic tests, and approaches to therapy. Therapeutic Archive, 9, 114–122.

Rubio–López, N., Morales–Suárez–Varela, M., Pico, Y., Livianos–Aldana, L., & Llopis–González, A. (2016). Nutrient Intake and Depression Symptoms in Spanish Children: The ANIVA Study. International Journal of Environmental Research and Public Health, 13 (3), 352. https://doi.org/10.3390/ijerph13030352

Marushko, Yu. V., Gy`shhak, T. V. (2016). Sovremennaya pediatriya, 6 (78), 27–32.

Astakhov, A. L. (2004). Liky Ukrainy, 1, 35–36.

Savchenko, V. N., Nikolenko, Ye. Ya., Kratenko, H. S., Pylypenko, N. O. (2014). Suchasni problemy medytsyny, 1, 68–71.

Vasenda, M. M., Hroshovyi, T. A., Belienichev, I. F., Kucherenko, L. I. (2010). Patent Ukrainy 51206 A 61 K 9/20. Likarskyi zasib na osnovi sumishi solei mahniiu z hlitsynom.

Yakovenko, O. V., Masliy, Ju. S. (2016). Study of physico-chemical and technological properties of active substances in the composition of medicated chewing gum. Aktual`ni py`tannya stvorennya novy`x likars`ky`x zasobiv: materialy XXIII mizhnarodnoi naukovo-praktychnoi konferentsii molodykh vchenykh ta studentiv. (21.04.2016). Kharkiv, 324–325.

Published

2019-11-19

Issue

Section

Biopharmaceutical research